The impact of clinical heterogeneity in schizophrenia on genomic analyses

Schizophrenia Research

Volumn 161, Issue 2-3, 2015, Pages 490-495

  Liang, Sherri G ^a   Greenwood, Tiffany A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diagnostics; Genome wide association; Heterogeneity; Schizophrenia

Indexed keywords

ARTICLE; COMORBIDITY; CONTROLLED STUDY; GENETIC HETEROGENEITY; GENETIC SCREENING; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CAUCASIAN; CHROMOSOME 9; GENE LINKAGE DISEQUILIBRIUM; GENETIC DATABASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROCEDURES; PSYCHOTIC DISORDERS;

CHROMOSOMES, HUMAN, PAIR 9; COMORBIDITY; DATABASES, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84921602108     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.11.019     Document Type: Article

References (59)

1. Adkins D.E., Aberg K., McClay J.L., Bukszar J., Zhao Z., Jia P., Stroup T.S., Perkins D., McEvoy J.P., Lieberman J.A., Sullivan P.F., van den Oord E.J. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol. Psychiatry 2011, 16(3):321-332.
2. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2(8):675-680.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, 4-Text Revision edition, (Washington DC).
4. Andreasen N.C. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995, 346(8973):477-481.
5. Bleuler E. Dementia Praecox oder Gruppe der Schizophrenien 1911, Deuticke, Leipzig.
6. Braff D.L., Freedman R. Endophenotypes in studies of the genetics of schizophrenia. Neuropsychopharmacology: The Fifth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology 2002, Lippincott Williams & Wilkins, Philadelphia. K.L. Davis, D. Charney, J.T. Coyle, C. Nemeroff (Eds.).
7. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61(11):1013-1021.
8. Craddock N., Owen M.J. The beginning of the end for the Kraepelinian dichotomy. Br. J. Psychiatry 2005, 186:364-366.
9. Cross-Disorder Group of the Psychiatric Genomics Consortium Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 2013, 45(9):984-994.
10. Crow T.J. The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture. Br. J. Psychiatry 1990, 156:788-797.
11. Cuthbert B.N., Insel T.R. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr. Bull. 2010, 36(6):1061-1062.
12. Fanous A.H., Neale M.C., Webb B.T., Straub R.E., Amdur R.L., O'Neill F.A., Walsh D., Riley B.P., Kendler K.S. A genome-wide scan for modifier loci in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(5):589-595.
13. Faraone S.V., Blehar M., Pepple J., Moldin S.O., Norton J., Nurnberger J.I., Malaspina D., Kaufmann C.A., Reich T., Cloninger C.R., DePaulo J.R., Berg K., Gershon E.S., Kirch D.G., Tsuang M.T. Diagnostic accuracy and confusability analyses: an application to the Diagnostic Interview for Genetic Studies. Psychol. Med. 1996, 26(2):401-410.
14. Ganguli R., Brar J.S., Rabin B.S. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv. Rev. Psychiatry 1994, 2(2):70-83.
15. Gershon E.S., Hamovit J., Guroff J.J., Dibble E., Leckman J.F., Sceery W., Targum S.D., Nurnberger J.I., Goldin L.R., Bunney W.E. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch. Gen. Psychiatry 1982, 39(10):1157-1167.
16. Gershon E.S., DeLisi L.E., Hamovit J., Nurnberger J.I., Maxwell M.E., Schreiber J., Dauphinais D., Dingman C.W., Guroff J.J. A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder. Arch. Gen. Psychiatry 1988, 45(4):328-336.
17. Gonzalez J.M., Xu H., Ofori E., Elovitz M.A. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?. Am. J. Obstet. Gynecol. 2007, 197(3):296.e1-296.e6.
18. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160(4):636-645.
19. Insel T.R., Cuthbert B.N. Endophenotypes: bridging genomic complexity and disorder heterogeneity. Biol. Psychiatry 2009, 66(11):988-989.
20. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167(7):748-751.
21. Ivleva E., Thaker G., Tamminga C.A. Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr. Bull. 2008, 34(4):734-742.
22. Karayiorgou M., Gogos J.A. A turning point in schizophrenia genetics. Neuron 1997, 19(5):967-979.
23. Kaul D., Habbel P., Derkow K., Kruger C., Franzoni E., Wulczyn F.G., Bereswill S., Nitsch R., Schott E., Veh R., Naumann T., Lehnardt S. Expression of Toll-like receptors in the developing brain. PLoS One 2012, 7(5):e37767.
24. Kawano H., Nakatani T., Mori T., Ueno S., Fukaya M., Abe A., Kobayashi M., Toda F., Watanabe M., Matsuoka I. Identification and characterization of novel developmentally regulated neural-specific proteins, BRINP family. Brain Res. Mol. Brain Res. 2004, 125(1-2):60-75.
25. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch. Gen. Psychiatry 1993, 50(12):952-960.
26. Kendler K.S., Karkowski L.M., Walsh D. The structure of psychosis: latent class analysis of probands from the Roscommon Family Study. Arch. Gen. Psychiatry 1998, 55(6):492-499.
27. Keshavan M.S., Morris D.W., Sweeney J.A., Pearlson G., Thaker G., Seidman L.J., Eack S.M., Tamminga C. A dimensional approach to the psychosis spectrum between bipolar disorder and schizophrenia: the Schizo-Bipolar Scale. Schizophr. Res. 2011, 133(1-3):250-254.
28. Kobayashi M., Nakatani T., Koda T., Matsumoto K., Ozaki R., Mochida N., Takao K., Miyakawa T., Matsuoka I. Absence of BRINP1 in mice causes increase of hippocampal neurogenesis and behavioral alterations relevant to human psychiatric disorders. Mol. Brain 2014, 7:12.
29. Kohane I.S. Deeper, longer phenotyping to accelerate the discovery of the genetic architectures of diseases. Genome Biol. 2014, 15:115.
30. Laje G., Paddock S., Manji H., Rush A.J., Wilson A.F., Charney D., McMahon F.J. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am. J. Psychiatry 2007, 164(10):1530-1538.
31. Larsen P.H., Holm T.H., Owens T. Toll-like receptors in brain development and homeostasis. Sci. STKE 2007, 2007(402):pe47.
32. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373(9659):234-239.
33. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O., Levinson D.F. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch. Gen. Psychiatry 1993, 50(11):871-883.
34. Manchia M., Cullis J., Turecki G., Rouleau G.A., Uher R., Alda M. The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PLoS One 2013, 8(10):e76295.
35. Muller N., Riedel M., Ackenheil M., Schwarz M.J. The role of immune function in schizophrenia: an overview. Eur. Arch. Psychiatry Clin. Neurosci. 1999, 249(Suppl. 4):62-68.
36. Neill N.J., Torchia B.S., Bejjani B.A., Shaffer L.G., Ballif B.C. Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH. Mol. Cytogenet. 2010, 3:11.
37. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Moller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nothen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40(9):1053-1055.
38. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34(5):269-281.
39. Owen M.J., Craddock N., Jablensky A. The genetic deconstruction of psychosis. Schizophr. Bull. 2007, 33(4):905-911.
40. Patni S., Wynen L.P., Seager A.L., Morgan G., White J.O., Thornton C.A. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol. Reprod. 2009, 80(2):243-248.
41. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediat. Inflamm. 2010, 2010.
42. Pruim R.J., Welch R.P., Sanna S., Teslovich T.M., Chines P.S., Gliedt T.P., Boehnke M., Abecasis G.R., Willer C.J. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010, 26(18):2336-2337.
43. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
44. Ruderfer D.M., Fanous A.H., Ripke S., McQuillin A., Amdur R.L., Gejman P.V., O'Donovan M.C., Andreassen O.A., Djurovic S., Hultman C.M., Kelsoe J.R., Jamain S., Landen M., Leboyer M., Nimgaonkar V., Nurnberger J., Smoller J.W., Craddock N., Corvin A., Sullivan P.F., Holmans P., Sklar P., Kendler K.S. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol. Psychiatry 2014, 19(9):1017-1024. Schizophrenia Working Group of the Psychiatric Genomics, Consortium., Bipolar Disorder Working Group of the Psychiatric Genomics, Consortium. Bipolar Disorder Working Group of the Psychiatric Genomics, Consortium., Cross-Disorder Working Group of the Psychiatric Genomics, Consortium.Cross-Disorder Working Group of the Psychiatric Genomics, Consortium.
45. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 2008, 165(4):497-506.
46. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43(10):969-976.
47. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
48. Schork N.J., Greenwood T.A., Braff D.L. Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research. Schizophr. Bull. 2007, 33(1):95-104.
49. Shi J., Levinson D.F., Duan J., Sanders A.R., Zheng Y., Pe'er I., Dudbridge F., Holmans P.A., Whittemore A.S., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Crowe R.R., Oksenberg J.R., Mirel D.B., Kendler K.S., Freedman R., Gejman P.V. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460(7256):753-757.
50. Smith E.N., Bloss C.S., Badner J.A., Barrett T., Belmonte P.L., Berrettini W., Byerley W., Coryell W., Craig D., Edenberg H.J., Eskin E., Foroud T., Gershon E., Greenwood T.A., Hipolito M., Koller D.L., Lawson W.B., Liu C., Lohoff F., McInnis M.G., McMahon F.J., Mirel D.B., Murray S.S., Nievergelt C., Nurnberger J., Nwulia E.A., Paschall J., Potash J.B., Rice J., Schulze T.G., Scheftner W., Panganiban C., Zaitlen N., Zandi P.P., Zollner S., Schork N.J., Kelsoe J.R. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol. Psychiatry 2009, 14(8):755-763.
51. Smith E.N., Koller D.L., Panganiban C., Szelinger S., Zhang P., Badner J.A., Barrett T.B., Berrettini W.H., Bloss C.S., Byerley W., Coryell W., Edenberg H.J., Foroud T., Gershon E.S., Greenwood T.A., Guo Y., Hipolito M., Keating B.J., Lawson W.B., Liu C., Mahon P.B., McInnis M.G., McMahon F.J., McKinney R., Murray S.S., Nievergelt C.M., Nurnberger J.I., Nwulia E.A., Potash J.B., Rice J., Schulze T.G., Scheftner W.A., Shilling P.D., Zandi P.P., Zollner S., Craig D.W., Schork N.J., Kelsoe J.R. Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet. 2011, 7(6):e1002134.
52. Somnath C.P., Janardhan Reddy Y.C., Jain S. Is there a familial overlap between schizophrenia and bipolar disorder?. J. Affect. Disord. 2002, 72(3):243-247.
53. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140(6):805-820.
54. Venkatasubramanian G., Debnath M. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) hypothesis: a novel postulate to understand schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 44:301-311.
55. Vieland V.J., Walters K.A., Lehner T., Azaro M., Tobin K., Huang Y., Brzustowicz L.M. Revisiting schizophrenia linkage data in the NIMH Repository: reanalysis of regularized data across multiple studies. Am. J. Psychiatry 2014, 171(3):350-359.
56. Vrijenhoek T., Buizer-Voskamp J.E., van der Stelt I., Strengman E., Sabatti C., Geurts van Kessel A., Brunner H.G., Ophoff R.A., Veltman J.A. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am. J. Hum. Genet. 2008, 83(4):504-510.
57. Wang K.S., Liu X.F., Aragam N. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr. Res. 2010, 124(1-3):192-199.
58. Weissman M.M., Gershon E.S., Kidd K.K., Prusoff B.A., Leckman J.F., Dibble E., Hamovit J., Thompson W.D., Pauls D.L., Guroff J.J. Psychiatric disorders in the relatives of probands with affective disorders. The Yale University-National Institute of Mental Health Collaborative Study. Arch. Gen. Psychiatry 1984, 41(1):13-21.
59. Winokur G., Tsuang M.T., Crowe R.R. The Iowa 500: affective disorder in relatives of manic and depressed patients. Am. J. Psychiatry 1982, 139(2):209-212.